Related Experiment Video
Updated: Sep 20, 2025

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
ERH Gene and Its Role in Cancer Cells
Kun Pang1, Mei-Li Li2,3, Lin Hao1
1Department of Urology, Xuzhou Central Hospital, Affiliated Central Hospital of Xuzhou Medical University, Xuzhou, China.
Abstract:
Cancer is a major public health problem worldwide. Studies on oncogenes and tumor-targeted therapies have become an important part of cancer treatment development. In this review, we summarize and systematically introduce the gene enhancer of rudimentary homolog (ERH), which encodes a highly conserved small molecule protein. ERH mainly exists as a protein partner in human cells. It is involved in pyrimidine metabolism and protein complexes, acts as a transcriptional repressor, and participates in cell cycle regulation. Moreover, it is involved in DNA damage repair, mRNA splicing, the process of microRNA hairpins as well as erythroid differentiation. There are many related studies on the role of ERH in cancer cells; however, there are none on tumor-targeted therapeutic drugs or related therapies based on the expression of ERH. This study will provide possible directions for oncologists to further their research studies in this field.
Insights
The gene enhancer of rudimentary homolog (ERH) plays roles in cell cycle and DNA repair. Further research into ERH expression could lead to novel tumor-targeted cancer therapies.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Cancer remains a significant global health challenge.
- Targeted therapies and oncogene research are crucial for cancer treatment development.
- The gene enhancer of rudimentary homolog (ERH) is a conserved protein involved in various cellular processes.
Purpose of the Study:
- To systematically review the known functions of ERH.
- To explore the potential of ERH as a target for tumor-specific therapies.
- To highlight research gaps and suggest future directions for oncologists.
Main Methods:
- Literature review of studies on ERH.
- Analysis of ERH's role in cellular pathways like pyrimidine metabolism, cell cycle regulation, DNA repair, and mRNA splicing.
- Examination of existing research on ERH in cancer cells.
Main Results:
- ERH is a highly conserved protein involved in critical cellular functions including DNA repair and cell cycle regulation.
- ERH acts as a transcriptional repressor and participates in protein complexes.
- While ERH's role in cancer cells is documented, no studies have explored ERH-based tumor-targeted therapies.
Conclusions:
- ERH is implicated in multiple cellular processes relevant to cancer.
- The lack of research on ERH-targeted therapies presents a significant opportunity.
- This review provides a foundation for developing novel ERH-based cancer treatments.
Related Concept Videos
Mitogens and the Cell Cycle
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
The Ras Gene
Ras is a...
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

